- Home
- AVBP vs QNST Comparison
AVBP vs QNST Comparison
Compare AVBP & QNST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AVBP
- QNST
- Stock Information
- Founded
- AVBP 2021
- QNST 1999
- Country
- AVBP United States
- QNST United States
- Employees
- AVBP N/A
- QNST N/A
- Industry
- AVBP
- QNST Business Services
- Sector
- AVBP
- QNST Consumer Discretionary
- Exchange
- AVBP NYSE
- QNST Nasdaq
- Market Cap
- AVBP 862.8M
- QNST 869.1M
- IPO Year
- AVBP 2024
- QNST 2010
- Fundamental
- Price
- AVBP $21.63
- QNST $15.54
- Analyst Decision
- AVBP Strong Buy
- QNST Strong Buy
- Analyst Count
- AVBP 8
- QNST 7
- Target Price
- AVBP $38.38
- QNST $28.29
- AVG Volume (30 Days)
- AVBP 484.4K
- QNST 465.9K
- Earning Date
- AVBP 08-13-2025
- QNST 08-07-2025
- Dividend Yield
- AVBP N/A
- QNST N/A
- EPS Growth
- AVBP N/A
- QNST N/A
- EPS
- AVBP N/A
- QNST N/A
- Revenue
- AVBP N/A
- QNST $1,029,978,000.00
- Revenue This Year
- AVBP $85.82
- QNST $80.76
- Revenue Next Year
- AVBP N/A
- QNST $7.94
- P/E Ratio
- AVBP N/A
- QNST N/A
- Revenue Growth
- AVBP N/A
- QNST 88.81
- 52 Week Low
- AVBP $15.47
- QNST $14.39
- 52 Week High
- AVBP $36.37
- QNST $26.27
- Technical
- Relative Strength Index (RSI)
- AVBP 47.74
- QNST 45.11
- Support Level
- AVBP $19.71
- QNST $15.34
- Resistance Level
- AVBP $22.32
- QNST $16.49
- Average True Range (ATR)
- AVBP 1.32
- QNST 0.45
- MACD
- AVBP -0.20
- QNST 0.00
- Stochastic Oscillator
- AVBP 31.89
- QNST 28.79
About AVBP ARRIVENT BIOPHARMA INC
ArriVent BioPharma Inc is a clinical-stage biopharmaceutical company dedicated to the identification, development, and commercialization of differentiated medicines to address the unmet medical needs of patients with cancers. It seeks to utilize the team's deep drug development experience to maximize the potential of the lead development candidate, furmonertinib, and advance a pipeline of novel therapeutics, such as next-generation antibody-drug conjugates, through approval and commercialization in patients suffering from cancer, with an initial focus on solid tumors.
About QNST QuinStreet Inc.
QuinStreet Inc focuses on marketplaces and technologies for the financial services and home services industries. It delivers measurable and cost-effective marketing results to its clients, in the form of qualified inquiries such as clicks, leads, calls, applications, or customers. It generates revenue by delivering measurable online marketing results to the clients. Its products and services are Customer Acquisition, QuinStreet Rating Platform (QRP), and CloudControlMedia.